13 December 2023 : Clinical Research
Comparative Evaluation of Contrast-Enhanced Spectral Mammography and Digital Breast Tomosynthesis for Diagnosing and Treating Breast Cancer
Di Yang1ABCDEF, Fei Gong2AG*DOI: 10.12659/MSM.941880
Med Sci Monit 2023; 29:e941880
Table 1 BI-RADS classification and pathological results of DBT and CESM.
| B1-RADS classification | Malignant | Benign | Total |
|---|---|---|---|
| DBT | |||
| BI-RADS 1, 2 | 5 | 4 | 9 |
| BI-RADS 3 | 1 | 1 | 2 |
| BI-RADS 4A | 7 | 25 | 32 |
| BI-RADS 4B | 17 | 24 | 41 |
| BI-RADS 4C | 22 | 0 | 22 |
| BI-RADS 5 | 18 | 1 | 19 |
| CESM | |||
| BI-RADS 1.2 | 0 | 0 | 0 |
| BI-RADS 3 | 0 | 9 | 9 |
| BI-RADS 4A | 4 | 31 | 35 |
| BI-RADS 4B | 5 | 6 | 11 |
| BI-RADS 4C | 11 | 2 | 13 |
| BI-RADS 5 | 50 | 7 | 57 |
| BI-RADS – Breast Imaging Reporting and Data System; DBT – digital breast tomosynthesis; CESM – contrast-enhanced spectral mammography. | |||